CD19 and neoplasm: Further investigation is warranted; extrapolation of these findings using real-world clinical testing for CD19 is not substantiated given the carefully controlled nature of the real-time fresh tumor quantitative flow assay by Spiegel et al. and the centralized and standardized nature of our IHC assay.